As of 4:00pm ET
| -0.04 / -0.44%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +53.68% increase from the last price of 9.11.
The current consensus among 3 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.